Introduction Biologic and small-molecule therapies have revolutionised the treatment of moderate-to-severe inflammatory bowel disease (IBD). A significant proportion of patients experience early or delayed treatment failure. Patients with IBD with greater visceral obesity are less likely to respond to biologics. https://safeersappliancers.shop/product-category/neff-ki8816de0-n90-a-e-built-in-fridge-289-litres-white/